Drugs / STA-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01484912 | May 2007 → Jun 2008 | intermediate coronary syndrome | Sinphar Pharmaceutical Co., Ltd | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STA-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01484912 ↗ |